Mark Morgan`
0000-0001-5245-1709
3 papers found
Refreshing results…
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) trial in acquired PARP-inhibitor-resistant homologous recombination deficient ovarian cancer
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma?
Missing publications? Search for publications with a matching author name.